tiprankstipranks
Trending News
More News >
CompuGroup Medical SE (DE:COP)
XETRA:COP
Germany Market

CompuGroup Medical (COP) Ratios

Compare
31 Followers

CompuGroup Medical Ratios

DE:COP's free cash flow for Q1 2025 was €0.84. For the 2025 fiscal year, DE:COP's free cash flow was decreased by € and operating cash flow was €0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.19 1.07 1.12 0.93 1.06
Quick Ratio
1.15 1.01 1.04 0.88 1.00
Cash Ratio
0.32 0.19 0.24 0.27 0.26
Solvency Ratio
0.11 0.13 0.15 0.15 0.16
Operating Cash Flow Ratio
0.39 0.52 0.39 0.41 0.52
Short-Term Operating Cash Flow Coverage
4.15 28.72 4.30 1.70 3.77
Net Current Asset Value
€ -922.76M€ -860.84M€ -849.81M€ -807.75M€ -618.72M
Leverage Ratios
Debt-to-Assets Ratio
0.45 0.40 0.40 0.41 0.35
Debt-to-Equity Ratio
1.36 1.15 1.17 1.21 0.87
Debt-to-Capital Ratio
0.58 0.53 0.54 0.55 0.46
Long-Term Debt-to-Capital Ratio
0.55 0.51 0.51 0.49 0.42
Financial Leverage Ratio
3.03 2.85 2.89 2.93 2.45
Debt Service Coverage Ratio
2.79 6.21 4.64 1.83 3.49
Interest Coverage Ratio
3.17 5.05 13.78 20.13 22.05
Debt to Market Cap
0.73 0.36 0.39 0.18 0.12
Interest Debt Per Share
17.65 15.15 15.23 14.27 10.42
Net Debt to EBITDA
3.74 3.25 3.01 2.93 2.47
Profitability Margins
Gross Profit Margin
83.64%84.62%84.81%84.97%85.15%
EBIT Margin
8.25%8.17%10.26%10.07%13.95%
EBITDA Margin
17.93%18.17%20.48%21.13%23.24%
Operating Profit Margin
9.16%10.35%11.12%10.60%14.29%
Pretax Profit Margin
5.36%6.12%9.45%9.55%13.19%
Net Profit Margin
3.00%3.87%6.50%6.73%8.74%
Continuous Operations Profit Margin
3.01%3.95%6.57%6.73%8.88%
Net Income Per EBT
55.90%63.18%68.73%70.47%66.28%
EBT Per EBIT
58.53%59.12%85.04%90.05%92.28%
Return on Assets (ROA)
1.76%2.42%3.78%3.85%4.67%
Return on Equity (ROE)
5.34%6.88%10.92%11.27%11.46%
Return on Capital Employed (ROCE)
6.47%7.92%8.01%7.81%9.38%
Return on Invested Capital (ROIC)
3.52%5.02%5.37%5.08%5.98%
Return on Tangible Assets
5.67%7.78%11.28%11.96%15.32%
Earnings Yield
3.07%2.31%3.91%1.85%1.73%
Efficiency Ratios
Receivables Turnover
5.73 5.63 5.09 5.62 -837.26K
Payables Turnover
2.02 2.22 1.55 1.65 1.93
Inventory Turnover
12.84 9.67 5.83 7.47 6.85
Fixed Asset Turnover
6.92 7.17 7.02 6.49 6.14
Asset Turnover
0.59 0.63 0.58 0.57 0.53
Working Capital Turnover Ratio
26.73 34.76 127.18 -205.25 117.89
Cash Conversion Cycle
-88.20 -61.82 -100.95 -106.82 -136.15
Days of Sales Outstanding
63.75 64.87 71.68 64.99 >-0.01
Days of Inventory Outstanding
28.43 37.74 62.62 48.88 53.32
Days of Payables Outstanding
180.38 164.43 235.26 220.69 189.46
Operating Cycle
92.18 102.61 134.31 113.87 53.32
Cash Flow Ratios
Operating Cash Flow Per Share
2.49 3.44 2.78 3.16 2.79
Free Cash Flow Per Share
1.27 1.99 1.23 1.68 1.75
CapEx Per Share
1.22 1.44 1.55 1.48 1.04
Free Cash Flow to Operating Cash Flow
0.51 0.58 0.44 0.53 0.63
Dividend Paid and CapEx Coverage Ratio
1.12 1.77 1.35 1.59 1.88
Capital Expenditure Coverage Ratio
2.04 2.38 1.79 2.13 2.69
Operating Cash Flow Coverage Ratio
0.15 0.23 0.18 0.22 0.27
Operating Cash Flow to Sales Ratio
0.11 0.15 0.13 0.16 0.18
Free Cash Flow Yield
5.83%5.25%3.40%2.36%2.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
32.54 43.23 25.60 53.98 57.70
Price-to-Sales (P/S) Ratio
0.98 1.67 1.66 3.63 5.04
Price-to-Book (P/B) Ratio
1.74 2.97 2.79 6.08 6.61
Price-to-Free Cash Flow (P/FCF) Ratio
17.15 19.06 29.37 42.42 44.83
Price-to-Operating Cash Flow Ratio
8.73 11.06 12.96 22.53 28.17
Price-to-Earnings Growth (PEG) Ratio
-1.36 -1.15 3.75 -18.35 0.00
Price-to-Fair Value
1.74 2.97 2.79 6.08 6.61
Enterprise Value Multiple
9.18 12.45 11.13 20.11 24.18
Enterprise Value
EV to EBITDA
9.18 12.45 11.13 20.11 24.18
EV to Sales
1.65 2.26 2.28 4.25 5.62
EV to Free Cash Flow
28.92 25.81 40.25 49.64 49.93
EV to Operating Cash Flow
14.73 14.97 17.76 26.36 31.37
Tangible Book Value Per Share
-13.67 -12.26 -11.87 -11.50 -8.36
Shareholders’ Equity Per Share
12.52 12.78 12.87 11.70 11.89
Tax and Other Ratios
Effective Tax Rate
0.44 0.36 0.31 0.29 0.34
Revenue Per Share
22.31 22.74 21.63 19.59 15.58
Net Income Per Share
0.67 0.88 1.41 1.32 1.36
Tax Burden
0.56 0.63 0.69 0.70 0.66
Interest Burden
0.65 0.75 0.92 0.95 0.95
Research & Development to Revenue
0.00 0.00 0.09 0.12 0.10
SG&A to Revenue
0.02 0.02 0.03 0.03 0.03
Stock-Based Compensation to Revenue
0.00 0.00 <0.01 <0.01 <0.01
Income Quality
3.71 3.83 1.96 2.39 2.04
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis